<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02858349</url>
  </required_header>
  <id_info>
    <org_study_id>2016-1916</org_study_id>
    <nct_id>NCT02858349</nct_id>
  </id_info>
  <brief_title>Mechanisms of Walking Recovery After Stroke</brief_title>
  <official_title>Mechanisms of Walking Recovery After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week
      control period and a 4-week exercise intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week
      control period and a 4-week exercise intervention using high-intensity interval training.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcomes Assessor was blinded to study design, including when participant was in control phase versus intervention phase</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Walking Speed</measure>
    <time_frame>Change from 4-weeks to 8-weeks</time_frame>
    <description>10-meter walk test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gait Symmetry</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
    <description>Paretic step ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic Cost of Gait</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
    <description>oxygen consumption rate during comfortable speed gait</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aerobic Capacity</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
    <description>oxygen consumption rate during exercise testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIH Toolbox - Cognition Domain</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIH Toolbox Standing Balance Test</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke and Aphasia Quality of Life Scale</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain Locomotor Network Activation</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain Locomotor Network Connectivity</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking Capacity</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
    <description>6-minute walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily Walking Activity</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
    <description>activity monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking Speed</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
    <description>10-meter walk test</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4-week control period with no intervention and 4-weeks of high-intensity interval training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High-intensity interval training</intervention_name>
    <description>High-intensity walking exercise using bursts of concentrated effort alternated with recovery periods</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 30-90 years

          -  unilateral stroke experienced &gt;6 months prior to enrollment in middle cerebral artery
             (MCA) territory without complete disruption of the putamen on the lesion side

          -  walking speed &lt;= 1.0 m/s on the 10 meter walk test

          -  able to walk 10m over ground with assistive devices as needed and no physical
             assistance

        Exclusion Criteria:

          -  MRI incompatibility (e.g. metallic or electronic implants, severe claustrophobia)

          -  inability to perform mental imagery (time dependent motor imagery screening test
             [TDMI])

          -  evidence of significant arrhythmia or myocardial ischemia on treadmill ECG stress
             test, or significant baseline ECG abnormalities that would make an exercise ECG
             uninterpretable

          -  recent (&lt;3 months) cardiopulmonary hospitalization

          -  unable to communicate with investigators or correctly answer consent comprehension
             questions

          -  significant ataxia or neglect (score of 2 on NIH stroke scale item 7 or 11)

          -  severe lower extremity (LE) spasticity (Ashworth &gt;2)

          -  recent (&lt;3 months) illicit drug or alcohol abuse or significant mental illness

          -  major post-stroke depression (PHQ-9 â‰¥10) in the absence of medical management

          -  participating in physical therapy or another interventional research study;

          -  recent (&lt;3 months) paretic LE botulinum toxin injection

          -  concurrent progressive neurologic disorder or other major medical, orthopedic or
             peripheral vascular conditions that would limit improvement

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierce Boyne, PT, DPT, NCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>July 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2016</study_first_posted>
  <results_first_submitted>November 26, 2018</results_first_submitted>
  <results_first_submitted_qc>November 26, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 15, 2019</results_first_posted>
  <last_update_submitted>November 26, 2018</last_update_submitted>
  <last_update_submitted_qc>November 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cincinnati</investigator_affiliation>
    <investigator_full_name>Pierce Boyne</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 24, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT02858349/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1</title>
          <description>4-week control period with no intervention and 4-weeks of high-intensity interval training
No intervention: No intervention
High-intensity interval training: High-intensity walking exercise using bursts of concentrated effort alternated with recovery periods</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>4-week control period with no intervention and 4-weeks of high-intensity interval training
No intervention: No intervention
High-intensity interval training: High-intensity walking exercise using bursts of concentrated effort alternated with recovery periods</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.8" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Comfortable Gait Speed, m/s</title>
          <units>meters per second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.41" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stroke Chronicity</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.4" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Walking Speed</title>
        <description>10-meter walk test</description>
        <time_frame>Change from 4-weeks to 8-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>4-week control period with no intervention and 4-weeks of high-intensity interval training
No intervention: No intervention
High-intensity interval training: High-intensity walking exercise using bursts of concentrated effort alternated with recovery periods</description>
          </group>
        </group_list>
        <measure>
          <title>Walking Speed</title>
          <description>10-meter walk test</description>
          <units>meters per second</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" lower_limit="0.05" upper_limit="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0042</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.05</ci_lower_limit>
            <ci_upper_limit>0.21</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gait Symmetry</title>
        <description>Paretic step ratio</description>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Metabolic Cost of Gait</title>
        <description>oxygen consumption rate during comfortable speed gait</description>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aerobic Capacity</title>
        <description>oxygen consumption rate during exercise testing</description>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NIH Toolbox - Cognition Domain</title>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NIH Toolbox Standing Balance Test</title>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stroke and Aphasia Quality of Life Scale</title>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Brain Locomotor Network Activation</title>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Brain Locomotor Network Connectivity</title>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Walking Capacity</title>
        <description>6-minute walk test</description>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Daily Walking Activity</title>
        <description>activity monitor</description>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Walking Speed</title>
        <description>10-meter walk test</description>
        <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Throughout study participation, which lasted approximately 4 months for each participant. The entire study lasted approximately 17 months.</time_frame>
      <desc>Each study visit, participant voluntary reporting of adverse events (AEs) was encouraged and AEs of interest were specifically queried, including: falls, orthopedic injuries, faintness, new/increased pain and muscle soreness. During clinical testing and training sessions, participants also had monitoring and post-session questioning to identify any signs or symptoms of cardiorespiratory insufficiency, new/worsening neurological impairments or orthopedic injury.</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>4-week control period with no intervention and 4-weeks of high-intensity interval training
No intervention: No intervention
High-intensity interval training: High-intensity walking exercise using bursts of concentrated effort alternated with recovery periods</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <description>Common cold</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="11" subjects_affected="5" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Joint stiffness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Increased knee hyperextension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Pain/soreness</sub_title>
                <counts group_id="E1" events="24" subjects_affected="7" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Surgical procedure</sub_title>
                <description>routine excision of ingrown toenail</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="11" subjects_affected="4" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pierce Boyne</name_or_title>
      <organization>University of Cincinnati</organization>
      <phone>5135587499</phone>
      <email>Pierce.Boyne@uc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

